474 件 ・ 関連度順
概要と使いどころ
Guides management of cross-border data transfers under Asia-Pacific regulatory frameworks including APEC CBPR, ASEAN Model Contractual Clauses, Japan APPI supplementary rules, South Korea PIPA provisions, and Thailand/Singapore PDPA mechanisms. Keywords: APEC CBPR, ASEAN MCCs, APPI, PIPA, PDPA, APAC transfers.
日本語の概要は準備中です。原文の説明を表示しています。
Identify EMERGING trends by connecting dots across unrelated sources. Monitor niche communities, academic research, GitHub, patents, funding, regulatory changes. Predict what will trend in 3-6 months based on weak signals.
日本語の概要は準備中です。原文の説明を表示しています。
Track compliance requirements and audit readiness. Trigger with "compliance", "audit prep", "SOC 2", "ISO 27001", "GDPR", "regulatory requirement", or when the user needs help tracking, preparing for, or documenting compliance activities.
日本語の概要は準備中です。原文の説明を表示しています。
Any live-web task via the Firecrawl CLI — including ordinary web research: searching the web, reading or extracting pages, gathering sources, discovering site URLs, bulk extraction, downloading a site, change alerts, or pages needing clicks/login — web only; local files route to firecrawl-parse. For US legal or regulatory questions use gov; for papers use firecrawl-research-index; for library, API, error, or bug questions use firecrawl-developer-index.
日本語の概要は準備中です。原文の説明を表示しています。
Build a preliminary, evidence-based EU AI Act readiness assessment across AI-system inventory, territorial scope, operator roles, prohibited-practice screening, risk classification, transparency, high-risk controls, general-purpose AI obligations, governance, and implementation milestones. Use when an organization needs to triage an AI use case, vendor, model, product, or portfolio for Regulation (EU) 2024/1689; prepare an AI inventory, gap register, implementation roadmap, or counsel briefing; assess provider, deployer, importer, distributor, product-manufacturer, authorised-representative, or GPAI-provider responsibilities; or re-check readiness after regulatory or product changes.
日本語の概要は準備中です。原文の説明を表示しています。
A high-level conceptual mapping from Active Directory attack techniques to the compliance controls they touch. Kerberoasting relates to authentication and logging, so it brushes ENS op.acc.5 / op.exp.8, NIS2 Art.21(2)(h), DORA RTS Art.9 / Art.21. Use this when a reader wants to understand which regulatory control an AD finding relates to, or to add an orientation note to a technical finding. This is a conceptual, orientative mapping only; it is NOT an auditor-defensible, curated, ID-by-ID control matrix. Covers ENS (op.acc.*, op.exp.*), NIS2 (Directive 2022/2555 Art.21), and DORA (RTS 2024/1774).
日本語の概要は準備中です。原文の説明を表示しています。
Risk analysis, regulatory risk assessment, competitive risk, macro risk, technology risk, litigation risk, financial risk assessment, enterprise risk, operational risk, geopolitical risk exposure
日本語の概要は準備中です。原文の説明を表示しています。
Med-adapted recent-quarter review: last print financials, pipeline-milestone awareness, and FDA-event context — reads the quarter through the med lens (milestones moved, runway, regulatory updates) rather than generic financials alone.
日本語の概要は準備中です。原文の説明を表示しています。
Sector overview, TAM estimation, competitive concentration HHI, regulatory landscape, industry analysis, market size analysis, sector trends, industry structure, market growth rate, sector profitability
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Flavor & Fragrance Chemist. Use when a task calls for Flavor & Fragrance Chemist judgment. Reasons from odor activity values, threshold perception, matrix release, and degradation kinetics through GC-MS with retention indices, GC-O/AEDA, chiral GC authentication, ISO 8586 trained sensory panels, and IFRA/FEMA regulatory limits while treating aldehyde oxidation, citral cyclization, top-note fade, and allergen exceedance as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Environmental Policy Analyst. Use when a task calls for Environmental Policy Analyst judgment. Reasons from statutory authority, baseline definition, and monetization boundaries through NEPA/ESA compliance, Circular A-4 RIAs, EPA SC-GHG and benefit transfer, IAM/IPCC scenario use, and APA regulatory comment while treating discount-rate dominance, weak transfer extrapolation, IAM structural uncertainty, and baseline inflation as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Developmental Biologist. Use when a task calls for Developmental Biologist judgment. Reasons from stage, positional information, gene regulatory networks, and tissue mechanics through morphology-based staging (Carnegie/HH/Theiler/NF/hpf), French-flag morphogen logic, light-sheet 4D imaging, lineage tracing, and ARRIVE/MDAR/REMBI reporting while treating developmental delay, CRISPR F0 mosaicism, morpholino p53 toxicity, and conflated fate-versus-lineage claims as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Automotive Engineer. Use when a task calls for Automotive Engineer judgment. Reasons from vehicle-level requirements, regulatory limits, energy/exergy budgets, and distribution-based durability through DFMEA/DVP&R, DoE calibration (INCA, CANape, HIL), Pacejka tire and multibody models, rainflow fatigue, and source-path NVH analysis while treating undocumented build-level and cal-ID deltas, unmet emissions preconditioning and OBD readiness, ADAS sensor misalignment, and cross-domain torque-arbitration conflicts as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Enrich any company with comprehensive firmographic data including industry, size, revenue, funding, tech stack, beneficial ownership, and regulatory status. Combines multiple data sources for complete B2B company intelligence and due diligence.
日本語の概要は準備中です。原文の説明を表示しています。
Query the Ensembl REST API for gene/transcript/protein lookup, sequence retrieval, comparative genomics (Compara), variant effect prediction (VEP), regulatory features, and cross-species ortholog/paralog calls. Use when pulling Ensembl-native data (Ensembl Gene IDs, version-pinned releases, archive endpoints for reproducibility), gene/transcript/exon structure with stable IDs, or VEP for variant annotation. Encodes the 15 req/sec rate limit, archive (e110.rest.ensembl.org) for reproducibility, Ensembl divisions (vertebrates / plants / fungi / metazoa / bacteria), and the symbol-vs-ID stability problem.
日本語の概要は準備中です。原文の説明を表示しています。
Reads, validates, and prepares CDISC SDTM and ADaM clinical trial data for analysis. Covers SDTM domain joins (DM, AE, EX, VS, LB, DS), ADaM architecture (ADSL, BDS, OCCDS, ADTTE) with traceability, treatment-emergent AE conventions, baseline derivation, SUPPQUAL/NSV handling, Define-XML 2.1, and Pinnacle 21 / CORE validation. Use when working with clinical trial datasets in CDISC SDTM/ADaM format, preparing analysis-ready data, or validating for regulatory submission.
日本語の概要は準備中です。原文の説明を表示しています。
End-to-end clinical trial analysis workflow from CDISC SDTM/ADaM loading through ICH E9(R1) estimand-driven primary analysis to CONSORT 2025 regulatory-compliant reporting. Covers data preparation, FDA 2023 marginal vs conditional logistic regression, categorical tests with Boschloo, modern HTE/subgroup methods, missing-data sensitivity (MMRM, reference-based MI, Permutt tipping point), graphical multiplicity (Bretz-Maurer), survival analysis (Cox/RMST/competing risks) when applicable, and Table 1. Use when performing a complete analysis of clinical trial data.
日本語の概要は準備中です。原文の説明を表示しています。
Build weighted gene co-expression networks to identify modules of co-regulated genes and relate them to phenotypes using WGCNA and CEMiTool. Detects hub genes and module-trait relationships from bulk or single-cell expression data. Use when finding co-expression modules, identifying hub genes, or relating gene networks to clinical or experimental variables.
日本語の概要は準備中です。原文の説明を表示しています。
Detect allele-specific chromatin accessibility from ATAC-seq using WASP, GATK ASEReadCounter, or RASQUAL. Use when mapping cis-regulatory genetic variants from heterozygous SNPs, separating cis from trans regulation, building chromatin QTL (caQTL) maps, validating GWAS variant function with allelic imbalance, or detecting reference allele mapping bias before downstream analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Workflow for paired or integrated single-cell RNA and ATAC analysis with multimodal latent spaces and regulatory interpretation.
日本語の概要は準備中です。原文の説明を表示しています。
Test payment and checkout flows end to end against PSP sandboxes — Stripe first, with the general pattern for Adyen/Braintree/PayPal. Covers Stripe test-mode card numbers and their decline codes, the 3DS/SCA challenge flow and its nested-iframe handling in Playwright, test clocks for subscription/billing-cycle simulation, webhook testing (stripe listen/trigger, signature verification, idempotency), failed/retried payments and refunds, and never using real cards. Use when: "test Stripe checkout," "payment test," "3DS test," "test webhook signature," "test subscription renewal," "test clock," "refund test," "decline card test," "checkout E2E." Not for: General API contract testing of non-payment endpoints — api-testing. PCI-DSS/regulatory compliance audit — compliance-testing. Related: api-testing, playwright-automation, compliance-testing, test-data-management, qa-project-context.
日本語の概要は準備中です。原文の説明を表示しています。
Test for regulatory compliance: GDPR/CMP consent verification, Google Consent Mode v2, Global Privacy Control (GPC), CCPA/US state opt-out, EU AI Act Article 50 transparency, Better Ads Standards, and cookie-inventory auditing. Covers automated consent-flow testing, third-party script blocking before consent, and cookie drift detection. Use when: "GDPR test," "compliance," "CMP test," "cookie consent," "consent mode," "CCPA," "GPC," "AI Act," "Better Ads," "privacy banner." Not for: WCAG/axe-core test authoring — use accessibility-testing. Not for: OWASP/vuln scanning — use security-testing. Not for: evaluating your LLM feature's quality or safety — use ai-system-testing. Related: accessibility-testing, security-testing, ai-system-testing, ci-cd-integration.
日本語の概要は準備中です。原文の説明を表示しています。
Implement tamper-evident audit logs for compliance (SOC 2, HIPAA, PCI DSS). Use when building compliance audit trails, tracking who did what and when, or implementing immutable event logs that satisfy regulatory retention requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Warren Buffett said he looks for "economic castles protected by unbreachable moats." A moat is a sustainable competitive advantage that protects your business from competitors. Without a moat, success attracts competition that erodes your margins to zero. This skill covers identifying, building, and deepening moats. Network effects, switching costs, brand, scale economies, and the rarer moats like regulatory capture and counter-positioning. Use when "moat, defensibility, competitive advantage, network effects, switching costs, barrier to entry, unfair advantage, protect from competition, sustainable advantage, winner take all, flywheel, lock-in, moat, defensibility, strategy, network-effects, switching-costs, competitive-advantage, seven-powers" mentioned.
日本語の概要は準備中です。原文の説明を表示しています。